BetterInfo on Women's PrEP Choices and Outcomes in Malawi
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-110
SponsorJohns Hopkins Bloomberg School of Public Health
About this trial
The purpose of this study is to understand PrEP user choices, preferences and implementation impact of the roll-out of long-acting injectable PrEP alongside oral PrEP among women in Blantyre, Malawi.
Eligibility criteria
Qualifiers
Adult women ≥18 years; and
Initiated PrEP (injectable or oral) at the implementing facilities and lost to follow up within prior 2 years prior to sampling; and
Lost-to-follow-up (missed their PrEP visit by ≥3 months and for whom outcomes are unknown); and
Has a registered phone number for contact
Disqualifiers
Women who have an EMR record of a documented case of discontinuation of PrEP in consultation with a provider; or
Women who are known to have died; or
Women who have EMR documented transfers out of PathToScale supported facilities; or
Women refusing follow-up via phone on their ScanForm; or
Trial design
Treatments tested in this trial
- Tracing Strategy
Treatment groups
384 Participants
are divided into 2 treatment groupsSponsors and collaborators
Johns Hopkins Bloomberg School of Public Health
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator
Kamuzu University of Health Sciences
Collaborator
Johns Hopkins Research Project, Malawi
Collaborator
Washington University School of Medicine
Collaborator
Source ClinicalTrials.gov